PAVmed, Inc. PAVM 深 滬
已收盤 04-02 16:00:00 美东时间
9.85
-0.390
-3.81%
華盛通- 最 高10.0051
- 今 開9.86
- 成交量 4718股
- 最 低 9.85
- 昨 收 10.24
- 總市值 6287.34万
- 52周最高 28.44
- 市盈率 靜 --
- 換手率 0.07%
- 52周最低 6.00
- 委 比 -90.11%
- 總股本 638.31万
- 歷史最高 6841.5963
- 量 比 0.24
- 振 幅 1.51%
- 歷史最低 6.00
- 每 手 1
- 風險率 4.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio. Octeris, Inc. subsidiary formed to advance endoscopic esophagea...
04-02 20:01
Earnings Scheduled For March 30, 2026
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers AstraZeneca PLC Ordinary Shares (NYSE:AZN) stock rose 107.1% to $192.1...
02-03 01:05
What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contract
01-22 22:23
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
01-22 01:05
Why Is PAVmed Stock Skyrocketing Wednesday?
Pavmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.
01-22 00:22
Lucid Diagnostics Wins VA Contract For EsoGuard, Expanding Esophageal Cancer Screening Across Nationwide VA Healthcare System
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it has been
01-21 21:10
PAVmed announces 1-for-30 reverse stock split
PAVmed (PAVM) will conduct a 1-for-30 reverse stock split of its common stock, effective on January 2, 2026, at 12:01 a.m. Eastern Time. The reverse stock split is intended to bring the company into c...
2025-12-30 22:29
PAVmed To Execute 1-For-30 Reverse Stock Split, Effective January 2, 2026
PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced it
2025-12-30 22:03
PAVmed Announces Reverse Stock Split
NEW YORK, Dec. 30, 2025 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, di...
2025-12-30 22:01
